Back to Browse Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 1

Factors affecting therapeutic compliance: A review from the patient’s perspective

Authors Jing Jin, Grant Edward Sklar, Vernon Min Sen Oh, Shu Chuen Li

Published 8 February 2008 Volume 2008:4(1) Pages 269—286

DOI http://dx.doi.org/10.2147/TCRM.S1458

Jing Jin1, Grant Edward Sklar1, Vernon Min Sen Oh2, Shu Chuen Li3

1Department of Pharmacy, National University of Singapore, Republic of Singapore; 2Department of Clinical Pharmacology and Therapeutics, Yong Loo Lin School of Medicine, National University of Singapore, Republic of Singapore; 3Discipline of Pharmacy and Experimental Pharmacology, School of Biomedical Sciences, University of Newcastle, Callaghan, Australia

Objective: To explore and evaluate the most common factors causing therapeutic noncompliance.

Methods: A qualitative review was undertaken by a literature search of the Medline database from 1970 to 2005 to identify studies evaluating the factors contributing to therapeutic non-compliance.

Results: A total of 102 articles was retrieved and used in the review from the 2095 articles identified by the literature review process. From the literature review, it would appear that the definition of therapeutic compliance is adequately resolved. The preliminary evaluation revealed a number of factors that contributed to therapeutic non-compliance. These factors could be categorized to patient-centered factors, therapy-related factors, social and economic factors, healthcare system factors, and disease factors. For some of these factors, the impact on compliance was not unequivocal, but for other factors, the impact was inconsistent and contradictory.

Conclusion: There are numerous studies on therapeutic noncompliance over the years. The factors related to compliance may be better categorized as “soft” and “hard” factors as the approach in countering their effects may differ. The review also highlights that the interaction of the various factors has not been studied systematically. Future studies need to address this interaction issue, as this may be crucial to reducing the level of non-compliance in general, and to enhancing the possibility of achieving the desired healthcare outcomes.

Keywords: patient compliance, adherence, factors

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Neural circuits in anxiety and stress disorders: a focused review

Duval ER, Javanbakht A, Liberzon I

Therapeutics and Clinical Risk Management 2015, 11:115-126

Published Date: 23 January 2015

Patient preference and ease of use for different coagulation factor VIII reconstitution device scenarios: a cross-sectional survey in five European countries

Cimino E, Linari S, Malerba M, Halimeh S, Biondo F, Westfeld M

Patient Preference and Adherence 2014, 8:1713-1720

Published Date: 12 December 2014

Medication adherence: process for implementation

Mendys P, Zullig LL, Burkholder R, Granger BB, Bosworth HB

Patient Preference and Adherence 2014, 8:1025-1034

Published Date: 28 July 2014

Zirconium, calcium, and strontium contents in magnesium based biodegradable alloys modulate the efficiency of implant-induced osseointegration

Mushahary D, Sravanthi R, Li Y, Kumar MJ, Harishankar N, Hodgson PD, Wen C, Pande G

International Journal of Nanomedicine 2013, 8:2887-2902

Published Date: 9 August 2013

Long-term safety of aromatase inhibitors in the treatment of breast cancer

Jean-Marc A Nabholtz

Therapeutics and Clinical Risk Management 2008, 4:189-204

Published Date: 8 February 2008

Treating oligohydramnios with extract of Salvia miltiorrhiza: A randomized control trial

Hong-nü Chu, Mei-juan Shen

Therapeutics and Clinical Risk Management 2008, 4:287-290

Published Date: 8 February 2008

Adult neural stem cells: The promise of the future

Philippe Taupin

Neuropsychiatric Disease and Treatment 2007, 3:753-760

Published Date: 15 January 2008